Advertisement
Home Tags Prescription Drugs

Tag: Prescription Drugs

Promoting generic substitution and therapeutic interchange can save money compared with spending on brand-name combination medications

Generic Substitutes, Therapeutic Interchange Can Save Money

Considerable savings estimated with use of generic substitutes for brand-name combo medications
For patients with rheumatoid arthritis

TNFi Not Linked to Increased Cancer Recurrence in RA Patients

No increased risk of cancer recurrence among RA patients initiating tumor necrosis factor inhibitor tx
For patients with melanoma and untreated brain metastases

Nivolumab + Ipilimumab Shows Efficacy for Untreated Brain Mets

Findings from open-label, phase 2 study in patients with melanoma and untreated brain metastases
Potential side effects of biological agents may increase anxiety in patients with rheumatic disease

Side Effects of Biologics for Rheumatic Dz May Up Anxiety

Common patient concerns are risks of cancer and tuberculosis activation
The expiration dates of certain batches of EpiPens have been extended by the U.S. Food and Drug Administration in an effort to reduce shortages of the life-saving devices.

FDA Extends EpiPen Expiration Dates to Tackle Shortage

Shortages due to factors such as supply disruptions and manufacturer issues
Many low-income urban preschool-aged children with asthma do not meet the criteria for home medication readiness

Many Children With Asthma Do Not Have Medications Ready

Low-income urban preschoolers with asthma may not meet home medication readiness criteria
From 2014 to 2017 there was an increase in tianeptine exposure calls reported by poison control centers to the National Poison Data System

CDC: Increase in Tianeptine Exposures From 2014 to 2017

Most commonly reported health effects were neurologic, cardiovascular, and gastrointestinal
The first generic version of the EpiPen has been approved by the U.S. Food and Drug Administration

FDA Approves First Generic EpiPen

Approval will address both rising costs and shortages of epinephrine
Methylphenidate should be considered as a first choice for the treatment of attention-deficit hyperactivity disorder in children and adolescents

Methylphenidate Good First-Choice Pediatric ADHD Drug

For adults, amphetamines are reasonable first choice to treat attention-deficit hyperactivity disorder
Ibalizumab has antiviral activity among patients with multidrug resistant HIV-1 infection

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Lower degree of susceptibility to ibalizumab for nine of 10 patients with virology failure, rebound